MiniMed app Downloads & RevenueMiniMed app · App Store
24 days old
Not in any tracked top chart right now.
Updated 8 Nov 2026 · rankings refresh through the day
DeveloperMiniMed
CategoryMedical
PriceFree
Released
Rating★ 0.0 (0)
Version1.4.0
Age rating9+
First seen by us
7 Nov 2026
Full timeline · 3 events
- 🆕MiniMed app first spotted by AppInsider#55 in Top Free · Medical · Italy
- 📦MiniMed app version 1.4.0No release notes
- 🆕MiniMed app released on the App Store
Collected from the stores by AppInsider since we first spotted the app. Dates are when we saw each change.
Rating
0.0 ★
0 ratings
Measured
MiniMed app on the App Store
App details
App ID
6759810766
Publisher
MEDTRONIC MINIMED INC
On the store since
Oct 2026
Under a year
Minimum OS
iOS 17.0+
iPhone XS and later
Devices
iPhone · iPad · Watch
Content rating
9+
Languages
1
EN
Size
219 MB
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| Not charting right now. | ||
Ratings
App Store, worldwide.
Rating
0.0 ★
0 ratings
Measured
Ratings
0
Measured
About MiniMed app
Manage your diabetes therapy with the MiniMed™ app! The MiniMed app connects to your MiniMed Flex™ pump system, letting you monitor glucose, adjust insulin delivery, and receive real-time alerts — all from your smartphone. View trends, track daily history, and get reminders for important actions. A new approach to making diabetes management simpler.
The app guides you through the startup process and provides an overview of data received from the MiniMed Flex pump and sensor. The MiniMed app is your primary source of information about your therapy and for controlling insulin delivery. Your data is automatically uploaded to CareLink™ software, simplifying the process of sharing information with your healthcare team and care partners. The MiniMed Flex system with SmartGuard™ feature automatically adjusts and corrects your sugar levels continuously throughout the day.§ Refers to SmartGuard™ feature. Individual results may vary.
Important: The MiniMed™ app is only compatible with the MiniMed Flex™ system, it does not work with other MiniMed™ pumps. The MiniMed™ app should only be used with supported mobile devices and operating systems. To access the list of the supported mobile devices and operating systems, go to your local MiniMed website.
The MiniMed Flex™ system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of diabetes mellitus in persons 2 years of age and older. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed Flex™ system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed Flex™ System consists of the following devices: MiniMed Flex™ Insulin Pump and the Simplera Sync™ sensor.
MiniMed Flex™ system is for persons 2 years of age and older. Prescription required. WARNING: Do not use SmartGuard™ feature for people who require less than 8 units or more than 250 units of insulin/day. For additional safety information and user guides.
WARNING: Do not use the MiniMed Flex™ system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed Flex™ system. Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed Flex™ system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its comp
The app guides you through the startup process and provides an overview of data received from the MiniMed Flex pump and sensor. The MiniMed app is your primary source of information about your therapy and for controlling insulin delivery. Your data is automatically uploaded to CareLink™ software, simplifying the process of sharing information with your healthcare team and care partners. The MiniMed Flex system with SmartGuard™ feature automatically adjusts and corrects your sugar levels continuously throughout the day.§ Refers to SmartGuard™ feature. Individual results may vary.
Important: The MiniMed™ app is only compatible with the MiniMed Flex™ system, it does not work with other MiniMed™ pumps. The MiniMed™ app should only be used with supported mobile devices and operating systems. To access the list of the supported mobile devices and operating systems, go to your local MiniMed website.
The MiniMed Flex™ system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of diabetes mellitus in persons 2 years of age and older. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed Flex™ system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed Flex™ System consists of the following devices: MiniMed Flex™ Insulin Pump and the Simplera Sync™ sensor.
MiniMed Flex™ system is for persons 2 years of age and older. Prescription required. WARNING: Do not use SmartGuard™ feature for people who require less than 8 units or more than 250 units of insulin/day. For additional safety information and user guides.
WARNING: Do not use the MiniMed Flex™ system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed Flex™ system. Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed Flex™ system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its comp
Latest updates
1.4.0